Thyroid receptor β: A promising target for developing novel anti-androgenetic alopecia drugs
- 3 May 2024
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (6) , 104013
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Androgenetic Alopecia: Therapy UpdateDrugs, 2023
- Female Androgenetic Alopecia: An Update on Diagnosis and ManagementAmerican Journal of Clinical Dermatology, 2019
- Roxadustat: First Global ApprovalDrugs, 2019
- Androgenetic alopecia: a reviewEndocrine, 2017
- Thyroid hormone receptors, cell growth and differentiationBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Thyroid hormone receptors: The challenge of elucidating isotype-specific functions and cell-specific responseBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Design, synthesis, and structure–activity relationship (SAR) of N-[7-(4-hydroxyphenoxy)-6-methylindan-4-yl]malonamic acids as thyroid hormone receptor β (TRβ) selective agonistsBioorganic & Medicinal Chemistry, 2013
- Efficacy and Safety of Finasteride Therapy for Androgenetic AlopeciaArchives of Dermatology, 2010
- Novel heterocyclic thyromimeticsBioorganic & Medicinal Chemistry Letters, 2005
- Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor betaBioorganic & Medicinal Chemistry Letters, 2004